Dr. Sandeep K. Thakkar, DO

Dr. Thakkar practices at Hoag Endoscopy Center - Irvine in Irvine, California.

Dr. Thakkar's NPI, 1740454586, was assigned on April 14, 2008. Dr. Thakkar graduated from WesternU College of Osteopathic Medicine of the Pacific in 2007. Dr. Thakkar holds California license 20A10840.

Dr. Thakkar's primary practice is Hoag Endoscopy Center - Irvine, at 16405 Sand Canyon Ave, Suite 110, Irvine, CA 92618. The practice phone is (949) 764-4448.

Dr. Thakkar's primary practice is Hoag Endoscopy Center - Irvine in Irvine, California. Dr. Thakkar is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Movement Disorder Parkinson’s Disease Specialists (MDPDS). Dmand AI also links Dr. Thakkar to 3 more hospitals, 3 home health agencies, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thakkar practices, 10 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Thakkar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Thakkar is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Thakkar is licensed in California.

Dmand AI lists acute mini-stroke (TIA), epilepsy, essential tremor, lower back pain, migraine and chronic headache, mobility impairment, muscle disease and neuropathy among the conditions Dr. Thakkar treats.

CMS data shows 150,519 Medicare services from Dr. Thakkar across 19 procedure codes in 2024, for 1,354 Medicare patients. Medicare paid $1,495,263 for them.

CMS counts 1,354 Medicare patients who saw Dr. Thakkar in 2024. The largest group is 75 to 84, with 646 patients. 75% of them have high cholesterol, and 75% have parkinson's disease. 7% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thakkar's median patient age at 76, with 51% women.

In 2024, Dr. Thakkar wrote 10,107 Medicare Part D claims for 1,414 patients. 78% of them were for generic drugs. CMS names the drug for 9,968 of them, across 61 drugs with 11 or more claims each, at $5,446,592 in total drug cost. In 2023, CMS named 9,642 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Thakkar for performance year 2024, reported individually. Dr. Thakkar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thakkar as offering telehealth.

Dmand AI links 4 papers to Dr. Thakkar, published from 2021 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Antiparkinson Agents, Carbidopa and Drug Combinations. Dr. Thakkar's most frequent co-authors are Rajesh Pahwa, MD, David G. Standaert and Leslie Jameleh Cloud, MD.

Dmand AI links Dr. Thakkar to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Huntington Disease and Chorea.

CMS Open Payments shows 4,597 general payments to Dr. Thakkar from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Neurocrine BioSciences, Inc. paid the most, $542,211. It also lists 34 research payments totaling $53,985 from 2018 to 2025.

Dr. Thakkar graduated from WesternU College of Osteopathic Medicine of the Pacific in 2007. Dr. Thakkar is a member of MDS.

Dr. Thakkar is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.